Biotech Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Elsevier MDL
Electronic laboratory notebooks for chemistry and biology are reviewed
June 23rd, 2006
Electronic laboratory notebooks for chemistry and biology are reviewed in a recent issue of Current Opinion in Drug Discovery and Development. According to the review, "Documenting an experiment in a way that ensures that the record can act as evidence to support a patent claim or to demonstrate compliance with the U.S. Food and Drug Administration's (FDA's) predicate rules puts demands on an electronic laboratory notebook (ELN) that are not trivial. The 1996 General Agreement on Tariffs and Trade (GATT) allowed notebook records that were generated outside of the U.S. to be used to claim precedence in U.S. patent claims. This agreement spurred interest in the...
Source: Biotech Law Weekly (2006-06-23)
|
